A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity

[1]  R. Brosch,et al.  A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity. , 2022, Cell reports.

[2]  P. Charneau,et al.  Un candidat vaccin lentiviral anti-Covid-19 administrable par voie intranasale , 2021, médecine/sciences.

[3]  S. Chardenoux,et al.  Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice , 2021, EMBO molecular medicine.

[4]  P. Charneau,et al.  Use of lentiviral vectors in vaccination , 2021, Expert review of vaccines.

[5]  P. Charneau,et al.  Lentiviral vector induces high-quality memory T cells via dendritic cells transduction , 2021, Communications biology.

[6]  N. Escriou,et al.  Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models , 2020, Cell Host & Microbe.

[7]  C. Leclerc,et al.  Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses. , 2019, Cell reports.

[8]  Yadira Lobaina Mato.  Nasal route for vaccine and drug delivery: features and current opportunities. , 2019, International journal of pharmaceutics.

[9]  F. Granucci,et al.  Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines , 2018, Front. Immunol..

[10]  R. Brosch,et al.  Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors , 2018, Cell reports.

[11]  T. Scriba,et al.  Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination , 2017, Front. Immunol..

[12]  N. Honoré,et al.  Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection. , 2017, Cell reports.

[13]  G. Mukamolova,et al.  Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection , 2017, Critical reviews in microbiology.

[14]  R. Noelle,et al.  Functions of CD40 and Its Ligand, gp39 (CD40L). , 2017, Critical reviews in immunology.

[15]  A. Kaprelyants,et al.  Rpf proteins are the factors of reactivation of the dormant forms of actinobacteria , 2016, Biochemistry (Moscow).

[16]  R. Brosch,et al.  ESX secretion systems: mycobacterial evolution to counter host immunity , 2016, Nature Reviews Microbiology.

[17]  Simon A. Jones,et al.  Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together , 2016, Front. Immunol..

[18]  R. Brosch,et al.  CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection , 2016, PLoS pathogens.

[19]  Justine D Mintern,et al.  Targeting dendritic cells: a promising strategy to improve vaccine effectiveness , 2016, Clinical & translational immunology.

[20]  B. Ueberheide,et al.  Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence , 2016, Proceedings of the National Academy of Sciences.

[21]  V. Bhat,et al.  A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model. , 2015, Vaccine.

[22]  A. Gitler,et al.  It's all starting to come together , 2015, eLife.

[23]  D. Barber,et al.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection. , 2015, Cold Spring Harbor perspectives in medicine.

[24]  R. Warren,et al.  Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity , 2015, Molecular microbiology.

[25]  A. Casadevall,et al.  Release of mycobacterial antigens , 2015, Immunological reviews.

[26]  F. Thiele,et al.  Modified Vaccinia Virus Ankara-Infected Dendritic Cells Present CD4+ T-Cell Epitopes by Endogenous Major Histocompatibility Complex Class II Presentation Pathways , 2014, Journal of Virology.

[27]  D. Barber,et al.  Intravascular staining for discrimination of vascular and tissue leukocytes , 2014, Nature Protocols.

[28]  R. Kornbluth,et al.  Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag , 2013, Journal of Virology.

[29]  A. B. Lyons,et al.  CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil? , 2013, Front. Immunol..

[30]  C. Leclerc,et al.  Induction of protective immunity against Mycobacterium tuberculosis by delivery of ESX antigens into airway dendritic cells , 2012, Mucosal Immunology.

[31]  I. Mellman,et al.  Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. , 2012, Blood.

[32]  R. Brosch,et al.  Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. , 2012, Cell host & microbe.

[33]  S. Nisole,et al.  HIV-derived vectors for therapy and vaccination against HIV. , 2012, Vaccine.

[34]  G. Fadda,et al.  PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis , 2012, Cellular microbiology.

[35]  R. Brosch,et al.  Disruption of the ESX‐5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation , 2012, Molecular microbiology.

[36]  T. Ottenhoff,et al.  Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. , 2012, Microbes and infection.

[37]  C. Leclerc,et al.  Complexes of Streptavidin-Fused Antigens with Biotinylated Antibodies Targeting Receptors on Dendritic Cell Surface: A Novel Tool for Induction of Specific T-Cell Immune Responses , 2012, Molecular Biotechnology.

[38]  J. Drijfhout,et al.  Identification of Human T-Cell Responses to Mycobacterium tuberculosis Resuscitation-Promoting Factors in Long-Term Latently Infected Individuals , 2011, Clinical and Vaccine Immunology.

[39]  Pin Wang,et al.  Immunization delivered by lentiviral vectors for cancer and infectious diseases , 2011, Immunological reviews.

[40]  W. Paul,et al.  Heterogeneity and plasticity of T helper cells , 2010, Cell Research.

[41]  M. Brennan,et al.  PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX‐5 , 2009, Molecular microbiology.

[42]  P. Andersen,et al.  Induction of CD8 T Cells against a Novel Epitope in TB10.4: Correlation with Mycobacterial Virulence and the Presence of a Functional Region of Difference-11 , 2007, The Journal of Immunology.

[43]  A. Surolia,et al.  Collectins: sentinels of innate immunity , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  T. Ottenhoff,et al.  Immunogenicity of Eight Dormancy Regulon-Encoded Proteins of Mycobacterium tuberculosis in DNA-Vaccinated and Tuberculosis-Infected Mice , 2006, Infection and Immunity.

[45]  Paul D van Helden,et al.  Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions , 2006, BMC Evolutionary Biology.

[46]  C. Leclerc,et al.  High Frequency of CD4+ T Cells Specific for the TB10.4 Protein Correlates with Protection against Mycobacterium tuberculosis Infection , 2006, Infection and Immunity.

[47]  P. Desprès,et al.  A single immunization with a minute dose of a lentiviral vector‐based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus , 2006, The journal of gene medicine.

[48]  B. Chain,et al.  Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  J. Van Damme,et al.  The CC chemokine CCL20 and its receptor CCR6. , 2003, Cytokine & growth factor reviews.

[50]  A. Kaprelyants,et al.  Proteins of the Rpf Family: Immune Cell Reactivity and Vaccination Efficacy against Tuberculosis in Mice , 2003, Infection and Immunity.

[51]  M. Kojima,et al.  Biochemistry and genetics of mannan-binding lectin (MBL). , 2003, Biochemical Society transactions.

[52]  Yu-Jin Jung,et al.  Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Sayera Banu,et al.  Are the PE‐PGRS proteins of Mycobacterium tuberculosis variable surface antigens? , 2002, Molecular microbiology.

[54]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[55]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[56]  A. Cunningham,et al.  Mycobacterial Stationary Phase Induced by Low Oxygen Tension: Cell Wall Thickening and Localization of the 16-Kilodalton α-Crystallin Homolog , 1998, Journal of bacteriology.

[57]  I. Ginjaar,et al.  The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. , 1987, Journal of immunology.

[58]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[59]  S. Papson,et al.  “Model” , 1981 .